Hermite
This article will help you quickly understand and start using the Hermite Computational Drug Design Platform.
Hermite Overview
Product Introduction
New drug discovery and development is a marathon, not a sprint. As the race heats up and low-hanging fruits are depleted, the resulting sharp increase in R&D costs and decrease in efficiency have become unbearable burdens for pharmaceutical companies, especially those focusing on novel drugs.
The "AI for Science“ (AI4S) research paradigm aims to revolutionize this landscape by harnessing artificial intelligence to tackle the intricate challenges of scientific research. By leveraging AI and molecular simulations, we can now explore the untapped biological, chemical, and physical spaces at atomic level, which may lead to novel discvoeries and significantly lowers the cost of drug development.
DP Technology is at the forefront of this approach, dedicated to integrating AI with advanced physics-based molecular simulation and computational techniques. Our goal is to address the critical scientific challenges of our time and lead the charge in developing a next-generation scientific computing and simulation platform.
Our flagship platform, Hermite is a testament to this commitment. Integrating artificial intelligence, physical modeling, and high-performance computing, Hermite provides a one-stop computational solution for preclinical drug R&D. It includes core functional modules such as protein structure prediction, drug-target binding evaluation, hit to lead screening and lead optimization.
Hermite is designed with the user in mind, providing a user-friendly, web-based platform that allows scientists to easily visualize, analyze, and collaborate on molecular data. It's equipped for both local setups and cloud-based applications, offering flexibility and ensuring data security for all your R&D needs.
Hermite Interface
Hermite offers a new generation of web-based interactive experiences for drug molecule design, allowing for comprehensive visualization of a variety of structures such as small molecules, (membrane) proteins, pharmacophores, drug-target interactions, with capability to precisely edit 2D and 3D drug molecules. The platform also features flexible molecule selection and diverse presentation options, all while ensuring seamless interaction across multiple windows for an intuitive user experience.
If you have any questions or need consultation
Please contact: support@atombeat.com